Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Strategic Partnership I | ViaCyte, Inc. | Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes | $9,475,070 |
| Accelerated Development Pathway I | ViaCyte, Inc. | Clinical Development of a Cell Therapy for Diabetes | $8,783,852 |
| Clinical Trial Stage Projects | ViaCyte, Inc. | Clinical trial of directly vascularized islet cell replacement therapy for high-risk type 1 diabetes | $19,752,463 |
Total: $38,011,385.00 |
